McKesson’s $2.25 Billion Precision Medicine Deal Puts Healthcare M&A in Focus
McKesson’s $2.25 billion Precision Medicine Group acquisition expands its healthcare-services footprint and puts sector consolidation under …
Martin Marietta’s Lhoist Combination Puts Strategic Weight Behind $MLM
Martin Marietta’s completed Lhoist North America combination expands its materials platform, putting integration and potential synergies in …
UPS Puts $2 Billion Behind a Higher-Margin Logistics Pivot
UPS is investing more than $2 billion in international, healthcare and supply chain operations as core parcel volumes remain under pressure.
Charter’s $1 Billion Cox Synergy Target Puts Cable Consolidation Back in Focus
Charter has closed its Cox acquisition, putting a potential $1 billion in annual synergies and integration execution at the center of the $C…
Citadel Unwinds More Than 80% of Situational Awareness Risk as Markets Navigate Rate Volatility
Citadel’s rare risk disclosure gives traders a fresh signal on positioning, liquidity and rate-driven volatility without revealing the portf…
Arctos’ Atlanta Falcons Deal Puts $10.6 Billion Sports Valuation in Focus
Arctos’ proposed 10% Falcons stake highlights institutional demand for scarce sports assets and potential implications for media-rights comp…
Stocks End Three-Day Slide as Falling Yields Lift Equities; Moderna Surges
U.S. stocks snapped a three-session decline as falling Treasury yields supported equities, while Moderna stood out and key technical support…
Curaleaf’s Hostile Aurora Cannabis Bid Sets Up a High-Stakes North American Cannabis Showdown
Curaleaf’s hostile bid for Aurora Cannabis creates binary deal risk, board resistance and potential volatility for both $CURA and $ACB.
Virtu Financial Rises on Takeover Speculation as Volatility Boosts Market-Maker Appeal
Virtu Financial gained amid takeover speculation, but no acquirer or deal terms were disclosed. Elevated volatility may add to the firm’s st…
Tech Selloff, Rising Bond Yields and Hormuz Tensions Pressure U.S. Stocks
U.S. stocks face a three-way test as technology weakens, bond yields rise and Hormuz tensions lift oil prices.
Curaleaf’s $4-A-Share Aurora Cannabis Bid Opens a New Chapter for North American Cannabis
Curaleaf’s $4-per-share bid for Aurora Cannabis creates a cross-border consolidation test and a potential merger-arbitrage setup.
Treasury Yield Shock and Hormuz Crisis Put US Stocks Under a Dual Macro Squeeze
A 19-year high in long-term Treasury yields and a Hormuz-driven oil shock are tightening conditions for US stocks, bonds and growth valuatio…